Effect of disease-modifying therapies on subcortical gray matter atrophy in multiple sclerosis

BACKGROUND: The effects of disease-modifying therapies (DMTs) on region-specific brain atrophy in multiple sclerosis (MS) are unclear. OBJECTIVE: To determine the effects of higher versus lower efficacy DMTs on rates of brain substructure atrophy in MS. METHODS: A non-randomized, observational cohor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mult Scler
Main Authors: Sotirchos, Elias S., Gonzalez-Caldito, Natalia, Dewey, Blake E., Fitzgerald, Kathryn C., Glaister, Jeffrey, Filippatou, Angeliki, Ogbuokiri, Esther, Feldman, Sydney, Kwakyi, Ohemaa, Risher, Hunter, Crainiceanu, Ciprian, Pham, Dzung L., Van Zijl, Peter C., Mowry, Ellen M., Reich, Daniel S., Prince, Jerry L., Calabresi, Peter A., Saidha, Shiv
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6689465/
https://ncbi.nlm.nih.gov/pubmed/30741108
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458519826364
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados